Advances in cancer treatment have led to longer life expectancies for patients diagnosed with many forms of the disease. However, with this extension in life expectancy comes the possibility of rather intense treatments including surgeries, chemo and radiation therapy, plus plenty of medications. Along with treatment comes pain as well. Most cancer patients experience severe pain and the management of which requires even more medications. All this leads to a drop in the quality of life. Doctors, researchers and regulators having successfully extended the lives of their patients, are now focused on boosting the quality of these new-found years. For this they require an accurate assessment of how the treatments they develop are working, from two perspectives, that of treating the cancer and how it makes the patient feel. Assessing effectiveness of the former is easy, for the latter however, doctors must fight through biases and even some long held stigmas surrounding medications. The goal of this research is to find new ways to assess the quality of life experienced by cancer patients undergoing treatment.